Human medicines European public assessment report (EPAR): Rebif, interferon beta-1a, Date of authorisation: 03/05/1998, Revision: 43, Status: Authorised

Human medicines European public assessment report (EPAR): Prasugrel Viatris (previously Prasugrel Mylan), prasugrel, Date of authorisation: 15/05/2018, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Ngenla, somatrogon, Date of authorisation: 14/02/2022, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Cinacalcet Accordpharma, cinacalcet, Date of authorisation: 03/04/2020, Revision: 6, Status: Authorised

European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes

European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure

Pre-submission interactions form for marketing authorisation application

Pre-submission interactions model pilot

Human medicines European public assessment report (EPAR): Imvanex, smallpox and monkeypox vaccine (Live Modified Vaccinia Virus Ankara), Date of authorisation: 31/07/2013, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Lokelma, sodium zirconium cyclosilicate, Date of authorisation: 22/03/2018, Revision: 13, Status: Authorised